HomeENTA • NASDAQ
add
Enanta Pharmaceuticals Inc
Previous close
$15.71
Day range
$15.84 - $17.05
Year range
$4.09 - $17.05
Market cap
479.12M USD
Avg Volume
361.21K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 15.12M | 3.55% |
Operating expense | 33.51M | -24.63% |
Net income | -18.70M | 35.12% |
Net profit margin | -123.64 | 37.34% |
Earnings per share | -0.87 | 36.03% |
EBITDA | -17.10M | 41.78% |
Effective tax rate | -0.17% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 188.86M | -23.90% |
Total assets | 280.73M | -25.47% |
Total liabilities | 216.02M | -12.84% |
Total equity | 64.72M | — |
Shares outstanding | 28.86M | — |
Price to book | 5.18 | — |
Return on assets | -15.80% | — |
Return on capital | -16.65% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -18.70M | 35.12% |
Cash from operations | -6.49M | 37.61% |
Cash from investing | 2.30M | -87.96% |
Cash from financing | -8.32M | -15.33% |
Net change in cash | -12.51M | -958.30% |
Free cash flow | -5.70M | 68.60% |
About
Founded
1995
Headquarters
Website
Employees
120
